Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy
Deepak Mishra(University of Delhi), Rachid Drissi(Nationwide Children's Hospital), Dhana Llivichuzhca-Loja(Yale University), Shiva Senthil Kumar(Nationwide Children's Hospital), Caterina Russo(McGill University Health Centre), Fupan Yao(Brain Tumour Research), Erin Crotty(Seattle Children's Hospital), Midori Clarke(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Shelli M. Morris(Center for Cancer and Blood Disorders), Andrew Bondoc(Brain Tumour Research), Annie Huang(Hospital for Sick Children), Liza Konnikova(Yale University), Xiaoting Zhu(Nationwide Children's Hospital), James M. Olson(Fred Hutch Cancer Center), Margo Coxon(Fred Hutch Cancer Center), Banlanjo Abdulaziz Umaru(Nationwide Children's Hospital), James T. Rutka(Hospital for Sick Children), Nada Jabado(McGill University), Dean Popovski(Uppsala University), Heather R. Conti(University of Dental Medicine), Matthew C. Biery(Seattle Children's Hospital), Mi‐Youn Brusniak(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Augusto Faria Andrade(McGill University Health Centre), Mei Lu(Hospital for Sick Children), Michele Zeinieh(McGill University Health Centre), Ken Brasel(Center for Cancer and Blood Disorders), Fiona Pakiam(Fred Hutch Cancer Center)
Cited by 5
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
|The Journal of Experimental Medicine|2009|999